We use cookies for a better user experience. Read our Privacy Policy

I Agree

Ocular Hypertension Treatment Market

Ocular Hypertension Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2030

Ocular Hypertension Treatment: Introduction

  • Ocular hypertension is caused by poor drainage of the fluid inside the eye. Essentially, this means that too much fluid enters the eye without being drained, causing high amount of pressure to build up.
  • An injury to the eye, certain diseases, and some medications could raise eye pressure

Key Drivers of Global Ocular Hypertension Treatment Market

  • Increase in incidence of ophthalmic diseases and constant rise in the geriatric population that is highly susceptible to eye disorders drive the global ocular hypertension treatment market
  • Eye-related disorders have emerged as potential threats to the populations in all middle-income and industrialized countries. Leading causes of vision impairment include uncorrected refractive errors, cataract, age-related macular degeneration, glaucoma, diabetic retinopathy, corneal opacity, and trachoma. Among these, cataract and uncorrected refractive errors are the most frequent and leading causes of blindness across the world.
  • According to the World Health Organization, an estimated 1.3 billion people were living with some form of vision impairment globally in 2018. According to CDC report, nearly 20.5 million (17.2%) people in the U.S. aged 40 years and above have cataract in one or both eyes, and 6.1 million (5.1%) have had their lens removed operatively. The total number of people who have cataract is projected to increase to 30.1 million by 2020.
  • Rise in awareness among people and increase in government initiatives for vision care management are anticipated to drive the global ocular hypertension treatment market

Intraocular Hypertension Segment to Dominate Global Market

  • In terms of type, the global ocular hypertension treatment market can be bifurcated into intraocular hypertension and glaucoma
  • The intraocular hypertension segment is expected to dominate the global market during the forecast period due to high prevalence of intraocular hypertension

Oral Segment to Lead Global Market

  • Based on route of administration, the global ocular hypertension treatment market can be classified into oral, parenteral, and others
  • The oral segment is likely to dominate the global market during the forecast period due to safety, good patient compliance, ease of ingestion, and no pain

Hospitals to be Highly Lucrative Segment

  • In terms of end-user, the global ocular hypertension treatment market can be categorized into hospitals, specialty clinics, and others
  • The hospitals segment is projected to account for major share of the global ocular hypertension treatment market by 2030 due to a large number of patients treated in hospitals for ocular hypertension treatment

North America to Offer Significant Opportunities in Ocular Hypertension Treatment Market

  • In terms of region, the global ocular hypertension treatment market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
  • North America dominated the global ocular hypertension treatment market in 2019. Availability of patient assistance programs and increase in research & development activities for the development of novel therapies are anticipated to drive the ocular hypertension treatment market in North America.

Key Players Operating in Global Ocular Hypertension Treatment Market

The global ocular hypertension treatment market is highly fragmented, with the presence of international and local players. Key players operating in the global ocular hypertension treatment market are:

  • Aerie Pharmaceuticals, Inc.
  • Allergan plc
  • Angelini Group
  • Chong Kun Dang Pharmaceutical Corp.
  • Laboratorios SALVAT SA
  • Laboratorios Sophia SA de CV
  • Lee's Pharmaceutical Holdings Ltd.
  • Neurim Pharmaceuticals Ltd.
  • NicOx SA
  • Novartis AG

Global Ocular Hypertension Treatment Market: Research Scope

Global Ocular Hypertension Treatment Market, by Type

  • Intraocular Hypertension
  • Glaucoma

Global Ocular Hypertension Treatment Market, by Route of Administration

  • Oral
  • Parenteral
  • Others

Global Ocular Hypertension Treatment Market, by End-user

  • Hospitals
  • Specialty Clinics
  • Others

Global Ocular Hypertension Treatment Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa
Ocular Hypertension Treatment Market

Interested in this report?
Get a FREE Brochure now!

Request Brochure

*Get Brochure (PDF) sent to your email within minutes

N/A

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

226

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved